A SINGLE CENTER REPORT OF THERAPEUTIC STRATEGIES IN PATIENTS WITH ATYPICAL CML (ACML) AND UNCLASSIFIED MDS/MPN (MDS/MPN-U)

被引：0
|
作者：
Braun, T. [1 ]
Debache, A. [1 ]
Roudot, H. [2 ]
Lusina, D. [2 ]
Thepot, S. [1 ]
Eclache, V. [2 ]
Martin, A. [3 ]
Soret, J. [1 ]
Brechignac, S. [1 ]
Kelaidi, C. [1 ]
Ades, L. [4 ]
Fenaux, P. [4 ]
Gardin, C. [1 ]
机构：
[1] Hop Avicenne, Hematol, F-93009 Bobigny, France
[2] Hop Avicenne, Lab Hematol, F-93009 Bobigny, France
[3] Hop Avicenne, Pathol, F-93009 Bobigny, France
[4] Hop St Louis, Hematol, Paris, France
来源：
LEUKEMIA RESEARCH | 2015年 / 39卷
关键词：
D O I：
10.1016/S0145-2126(15)30206-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
205
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 39 条
  • [21] MDS/MPN-U with persistent monocytosis, del(20q), and CALR mutation, the great masquerader
    Xu, Zhaodong
    Berry, Brian R.
    BLOOD, 2020, 135 (19) : 1718 - 1718
  • [22] Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): More than just a "catch-all" term?
    Shallis, Rory M.
    Zeidan, Amer M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (02)
  • [23] SINGLE-CENTER EXPERIENCE OF AZACITIDINE-VENETOCLAX IN SECONDARY ACUTE MYELOID LEUKEMIA (AML), ARISING FROM MYELODYSPLASTIC SYNDROME (MDS), MYELOPROLIFERATIVE NEOPLASM (MPN) OR MDS/MPN OVERLAP
    Halim, N. A. Abdul
    Chan, T. W.
    Wong, G. C.
    Than, H.
    LEUKEMIA RESEARCH, 2023, 128
  • [24] Outcome of MDS, MDS/MPN Patients Aged <65 Treated with Hypomethylating Agents as a Bridge to Transplant in a Single Tertiary-Care Italian Center
    Fani, Arianna
    Attardi, Enrico
    Gozzini, Antonella
    Guidi, Stefano
    Saccardi, Riccarco
    Santini, Valeria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S346 - S346
  • [25] Myelodysplastic/Myeloproliferative Neoplasms, Unclassifiable (MDS/MPN, U): Natural History and Clinical Outcome By Therapeutic Approach
    DiNardo, Courtney D.
    Daver, Naval G.
    Jain, Nitin
    Pemmaraju, Naveen
    Bueso-Ramos, Carlos E.
    Yini, Cheng
    Pierce, Sherry R.
    Jabbour, Elias
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Verstovsek, Srdan
    BLOOD, 2013, 122 (21)
  • [26] Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients
    Abhishek A. Mangaonkar
    David M. Swoboda
    Giacomo Coltro
    Terra L. Lasho
    Paul J. Novotny
    Prateek Pophali
    Ryan M. Carr
    Moritz Binder
    Christy M. Finke
    Naseema Gangat
    Aref Al-Kali
    Kebede H. Begna
    Kaaren K. Reichard
    Rhett P. Ketterling
    Najla H. Al Ali
    Pardis Vafaii
    Ling Zhang
    Eric Padron
    Chetasi Talati
    Mrinal M. Patnaik
    Leukemia, 2020, 34 : 656 - 661
  • [27] Clinicopathologic characteristics, prognostication and treatment outcomes for myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U): Mayo Clinic-Moffitt Cancer Center study of 135 consecutive patients
    Mangaonkar, Abhishek A.
    Swoboda, David M.
    Coltro, Giacomo
    Lasho, Terra L.
    Novotny, Paul J.
    Pophali, Prateek
    Carr, Ryan M.
    Binder, Moritz
    Finke, Christy M.
    Gangat, Naseema
    Al-Kali, Aref
    Begna, Kebede H.
    Reichard, Kaaren K.
    Ketterling, Rhett P.
    Al Ali, Najla H.
    Vafaii, Pardis
    Zhang, Ling
    Padron, Eric
    Talati, Chetasi
    Patnaik, Mrinal M.
    LEUKEMIA, 2020, 34 (02) : 656 - 661
  • [28] CMML and aCML share mutated genes and can be discriminated from MDS/MPN, U and RARS-T: The mutational landscape of 18 investigated genes in 177 patients
    Meggendorfer, M.
    Haferlach, T.
    Haferlach, C.
    Kern, W.
    Schnittger, S.
    Oncology Research and Treatment, 2015, 38 : 215 - 216
  • [29] Treatment of progression of myeloproliferative neoplasm (MPN) to MDS/AML by azacytidine (AZA): a report on 44 patients (pts)
    Thepot, S.
    Itzykson, R.
    Raffoux, E.
    Recher, C.
    Quesnel, B.
    Dreyfus, F.
    Cluzeau, T.
    Chait, Y.
    Cassinat, B.
    Zerhouni, C.
    Roussel, M.
    Kiladjian, J.
    Gardin, C.
    Fenaux, P.
    Ades, L.
    LEUKEMIA RESEARCH, 2009, 33 : S132 - S133
  • [30] OUTCOMES OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN PATIENTS WITH MDS/MPN OVERLAP SYNDROMES-A SINGLE INSTITUTIONAL EXPERIENCE
    Sharma, P.
    Shinde, S.
    Gangat, N.
    Al-Kali, A.
    Hashami, S.
    Litzow, M.
    Hogan, W.
    Khan, S.
    Rodriguez, V.
    Patnaik, M.
    HAEMATOLOGICA, 2015, 100 : 283 - 283
1234